ash impact series: paul richardson, md - examining the new fda approved myeloma drug products
Published 8 years ago • 355 plays • Length 6:17
Download video MP4
Download video MP3
Similar videos
-
6:35
ash impact series: vincent rajkumar, md - examining the new fda approved myeloma drug products
-
37:46
current and future directions for novel therapy for multiple myeloma: paul g. richardson, md
-
8:06
mezigdomide (cc-92480) | paul richardson, md | ash 2022
-
1:09:44
2024 mid-year myeloma review with paul richardson, md, dana farber cancer institute
-
35:50
dr. paul richardson on novel approaches for treating multiple myeloma | dana-farber cancer institute
-
7:32
myeloma determination study | paul richardson, md | ims 2022
-
3:10
ash impact series: sagar lonial, md - examining multiple myeloma drug combination treatments
-
5:03
paul richardson: isatuximab improves pfs in relapsed/refractory myeloma
-
1:51
key studies on multiple myeloma presented at ash 2016
-
1:28:01
myeloma crowd: paul richardson, md, dana farber cancer institute
-
1:28:28
mpatient myeloma radio: dr. paul richardson, md, dana-farber cancer institute
-
1:01:20
myeloma crowd radio: paul richardson, md, dana farber cancer institute
-
1:57
paul richardson's angiopathy highlights
-
1:08:15
healthtree podcast for multiple myeloma: paul richardson, md, dana farber
-
1:37
the status quo is not enough: dr. paul richardson | dana-farber cancer institute
-
7:26
treatment options for frail patients at early relapse | paul richardson, md | ims 2023
-
2:47
mezigdomide plus dexamethasone in rrmm: cc-92480-mm-002 trial results| paul richardson, md |ash 2023
-
5:07
a new horizon: melflufen for r/r multiple myeloma
Clip.africa.com - Privacy-policy